Quarterly report pursuant to Section 13 or 15(d)

EMPLOYEE STOCK PLANS - Stock Option Activity (Details)

v3.24.1.u1
EMPLOYEE STOCK PLANS - Stock Option Activity (Details) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Feb. 29, 2024
Feb. 28, 2023
Feb. 29, 2024
Feb. 28, 2023
Aug. 31, 2023
Aug. 31, 2022
Jan. 19, 2024
Stock Options [Abstract]              
Exercised (in shares) 13,978 0 13,978 0      
Options cancelled (in shares) 18,022   18,022        
2014 Equity Plan              
Shareholders' Equity [Abstract]              
Shares reserved for issuance (in shares) 1,600,000   1,600,000        
Shares available for grant (in shares) 956,364   956,364   964,378    
Number of Options [Roll Forward]              
Outstanding, beginning of period (in shares)     563,000 712,500 712,500    
Net settlement exercised (in shares)     (32,000)        
Outstanding, end of period (in shares) 531,000 712,500 531,000 712,500 563,000 712,500  
Options exercisable (in shares) 472,000   472,000        
Weighted Average Exercise Price [Roll Forward]              
Outstanding, beginning of period (in dollars per share)     $ 9.15 $ 8.75 $ 8.75    
Outstanding, end of period (in dollars per share) $ 9.36 $ 8.75 9.36 $ 8.75 $ 9.15 $ 8.75  
Options exercisable (in dollars per share) $ 9.18   $ 9.18        
Stock Options [Abstract]              
Weighted average remaining contractual term     5 years 2 months 12 days 5 years 5 years 6 months 5 years 8 months 12 days  
Weighted average remaining contractual term, options exercisable     5 years        
Approximate aggregate intrinsic value, outstanding $ 689,000 $ 1,000 $ 689,000 $ 1,000 $ 1,221,000 $ 1,489,000  
Approximate aggregate intrinsic value, options exercisable $ 656,000   $ 656,000        
2024 Equity Plan              
Shareholders' Equity [Abstract]              
Authorized shares of common stock for issuance (in shares)             2,000,000
Shares available for grant (in shares) 2,000,000   2,000,000